戻る Agenda
Panel Discussion (Session 2 & 3)
Session Chair(s)
Koichi Miyazaki, PHD
Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan
Yoshiaki Uyama, PHD, MS, RPH
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gau Churn-Shiouh, DRSC
Project Office of Sustainable Platform For Big Data In Health by MOHW, Ching-Kan, Taiwan
Office Director
Sun-young Kim, MS
Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Assistant Director, Clinical Trials Management Div, Pharmaceutical Safety Bureau
Akihiro Ishiguro, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Head of PMDA, Washington D.C. Office
Tetsuomi Takano, RPH
Drug R&D Expert, Japan
Editor-in-Chief
Yamin Wang, PHD
Bayer (South East Asia) Pte Ltd., Germany
Vice President & Head of Regulatory Affairs, Therapeutic Area General Medicine
Minsoo Park
KCGI, Korea, Republic of